Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 43.84B | 43.49B | 41.18B | 38.26B | 32.29B | 27.99B |
Gross Profit | 32.49B | 32.26B | 30.42B | 27.68B | 23.85B | 20.46B |
EBITDA | 11.03B | 10.39B | 9.66B | 9.16B | 7.54B | 6.47B |
Net Income | 6.12B | 6.41B | 6.18B | 5.71B | 4.60B | 3.56B |
Balance Sheet | ||||||
Total Assets | 54.60B | 56.35B | 51.86B | 46.84B | 43.01B | 43.61B |
Cash, Cash Equivalents and Short-Term Investments | 4.82B | 4.08B | 4.32B | 2.62B | 2.72B | 6.41B |
Total Debt | 8.83B | 8.49B | 8.69B | 5.65B | 6.30B | 2.55B |
Total Liabilities | 23.42B | 23.22B | 22.77B | 19.66B | 19.42B | 14.61B |
Stockholders Equity | 31.18B | 33.13B | 29.07B | 27.18B | 23.59B | 28.99B |
Cash Flow | ||||||
Free Cash Flow | 7.40B | 6.64B | 6.12B | 4.93B | 5.65B | 5.48B |
Operating Cash Flow | 9.02B | 8.29B | 7.60B | 6.28B | 6.73B | 6.45B |
Investing Cash Flow | -1.39B | -3.70B | -4.14B | -2.22B | -1.63B | -2.64B |
Financing Cash Flow | -5.46B | -4.79B | -1.61B | -4.08B | -8.86B | -2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | €207.98B | 34.09 | 20.13% | 1.79% | 2.60% | -5.44% | |
75 Outperform | €7.99B | 11.82 | 16.07% | 16.27% | 6.71% | 141.19% | |
75 Outperform | €2.51B | 17.89 | 20.31% | 3.03% | 9.68% | 19.46% | |
73 Outperform | €1.62B | 17.47 | 18.22% | 1.22% | 10.55% | 13.50% | |
64 Neutral | €4.94B | 9.84 | ― | 5.86% | 7.04% | 73.35% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | €49.70M | 12.10 | ― | 4.55% | -3.97% | -269.15% |